Sanders Corazon (Corsee) D.
Transaction: 06/17/2026
OTHER
Change
0
Price
Not reported
Filing
06/29/2026
Type
OTHER
Calidi Biotherapeutics, Inc.
CLDI • Biotechnology
$0.76
▼ -0.01 (-1.43%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.10M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.68Healthy liquidity · 1.59Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:24 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.76
Change-1.43%
Shares Out1.42M
Market Cap$1.10M
Enterprise Value$-1.63M
52W Range1.25 - 30.08
Beta1.33
P/E-0.06
P/B0.35
P/FCF-0.06
EV/EBITDA0.10
EV/FCF0.09
Price$0.76
Change-1.43%
Shares Out1.42M
Market Cap$1.10M
Enterprise Value$-1.63M
52W Range1.25 - 30.08
Beta1.33
P/E-0.06
P/B0.35
P/FCF-0.06
EV/EBITDA0.10
EV/FCF0.09
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.68
Current Ratio1.59
Quick Ratio1.59
Target$5.50
Target Upside624.64%
Target Median$5.50
Target Range2.00 - 9.00
Volume134.72K
Avg Volume405.15K
EPS Surprise0.99
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Manageable debt level · 0.68Healthy liquidity · 1.59Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-19
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-20
Low
$2.00
Mean
$5.50
Median
$5.50
High
$9.00
Insider Transactions
Recent executive and insider activity
Camaisa Allan
Transaction: 12/12/2025
SELL
Change
-850
Price
$1.46
Filing
12/16/2025
Type
SELL
Jackson Andrew C.
Transaction: 09/03/2025
BUY
Change
+30,000
Price
$1.58
Filing
09/05/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | OTHER | 0 | Not reported | 06/17/2026 | 06/29/2026 |
| Camaisa Allan | SELL | -850 | $1.46 | 12/12/2025 | 12/16/2025 |
| Jackson Andrew C. | BUY | +30,000 | $1.58 | 09/03/2025 | 09/05/2025 |
| Fernandez Santidrian Antonio | BUY | +35,000 | $1.58 | 09/03/2025 | 09/05/2025 |
| Poma Eric E | BUY | +10,000 | $1.58 | 09/03/2025 | 09/05/2025 |
| Lincoln Alternative Strategies LLC | OTHER | 0 | Not reported | 08/20/2025 | 08/27/2025 |
| Jackson Andrew C. | BUY | +2,500 | $2.00 | 08/21/2025 | 08/25/2025 |
| Jackson Andrew C. | BUY | +2,500 | $2.00 | 08/21/2025 | 08/25/2025 |
| Leftwich Scott | BUY | +125,000 | $2.00 | 08/21/2025 | 08/25/2025 |
| Leftwich Scott | BUY | +125,000 | $2.00 | 08/21/2025 | 08/25/2025 |
| Poma Eric E | BUY | +25,000 | $2.00 | 08/21/2025 | 08/25/2025 |
| Poma Eric E | BUY | +25,000 | $2.00 | 08/21/2025 | 08/25/2025 |
| Schoeneck James A | BUY | +75,000 | $2.00 | 08/21/2025 | 08/25/2025 |
| Schoeneck James A | BUY | +75,000 | $2.00 | 08/21/2025 | 08/25/2025 |
| Leftwich Scott | BUY | +137,078 | $0.70 | 07/09/2025 | 07/15/2025 |
| Peoples George | BUY | +137,078 | $0.70 | 07/09/2025 | 07/15/2025 |
| Stewart Alan R. | BUY | +137,078 | $0.70 | 07/09/2025 | 07/15/2025 |
| Schoeneck James A | BUY | +164,493 | $0.70 | 07/09/2025 | 07/15/2025 |
| Poma Eric E | OTHER | 0 | Not reported | 04/22/2025 | 04/25/2025 |
| Poma Eric E | BUY | +726,412 | $0.47 | 04/22/2025 | 04/25/2025 |